JP/ZH: Currently, only the Luminex LTG section and the Service & Support pages regarding Luminex LTG are available in Japanese/Chinese.
29/01/26 - 7:03
Diasorin has been granted De novo authorization in the U.S. for the First Fully Automated Laboratory Test for Hepatitis Delta Virus (HDV) on the LIAISON XL (128.56 KB)
27/01/26 - 16:05
The Shareholders' meeting authorized the purchase of treasury shares, approved the amendment of art. 5 of the articles of association and authorized the cancellation of treasury shares. The Board approved the launch of the buyback plan. (120.91 KB)
26/01/26 - 7:09
Diasorin signs exclusive distribution agreement for the LIAISON NES® molecular point‑of‑care platform and the Flu A/B, RSV & Covid‑19 panel (131.63 KB)
23/01/26 - 17:49
Succession in the role of Group Chief Financial Officer of Diasorin. Alberto Donati appointed new Group Chief Financial Officer. (108.99 KB)
23/12/08 - 1:00
Financial instruments to employees (26.19 KB)
21/11/08 - 1:00
Financial instruments to employees (23.66 KB)
13/11/08 - 1:00
The BoD approves Q3'08 results (171.93 KB)
22/09/08 - 2:00
Agreement in Japan with Advanced Life Science Institute (99.16 KB)
08/08/08 - 2:00
The BoD approves H1'08 results (194.3 KB)
09/07/08 - 2:00
Acquisition of Biotrin (99.08 KB)
16/05/08 - 2:00
Financial instruments to employees (23.28 KB)
15/05/08 - 2:00
Results for Q1'08 (159.78 KB)
24/04/08 - 2:00
2007 statutory financial Statements approved (93.67 KB)
21/04/08 - 2:00
2008 Financial calendar update (93.56 KB)
19/03/08 - 1:00
The BoD approves FY 2007 results (198.25 KB)
14/02/08 - 1:00
The BoD approves Q4'07 results (170.91 KB)
29/01/08 - 1:00
2008 Financial calendar (88.78 KB)
07/01/08 - 1:00